The global clinical laboratory services market size is expected to reach USD 286.77 billion by 2030, registering a CAGR of 3.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the industry can be attributed to the increasing prevalence of the geriatric population, which, in turn, is propelling the demand for early disease diagnosis. The growing prevalence of target diseases, such as diabetes and Cardiovascular Diseases (CVDs), is a high impact-rendering driver for industry growth over the forecast period. Cardiovascular disease is the leading cause of death globally. The presence of unmet medical needs pertaining to disease management and the subsequent increase in patient awareness in more regions are expected to boost the demand for clinical laboratory testing.
Improvements in laboratory testing technology through break through and incremental advances are high-impact-rendering drivers for industry growth. Market firms are engaged in introducing new Servicess to serve the unmet demand of patients. For instance, in May 2022, Hamilton County entered into a partnership with Ethos Laboratories for the launch of no-cost COVID-19 testing sites. In July 2022, Mayo Clinic laboratories launched monkeypox tests to increase availability and accessibility to a wider target population. Moreover, in January 2022, Quest Diagnostics launched COVID-19 rapid antigen tests available through QuestDirect in collaboration with eMed to provide access to testing for COVID-19 at home. The pandemic affected millions of people globally. According to the CDC and WHO, the standard for diagnosis of COVID-19 is RT-PCR for samples from the respiratory tract.
The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure is driving the industry. Due to this pandemic, there is an increase in the approval of tests for the diagnosis of the novel coronavirus, with most of these tests approved under Emergency Use Authorization (EUA) by federal agencies. Furthermore, the industry operates through different sales channels-laboratories and hospitals. The presence of prominent players in various regions is expected to drive the industry. For instance, in February 2022,Labcorp entered into a comprehensive partnership with Ascension. Through this collaboration, Labcorp will handle Ascension’s hospital-based labs situated in ten states for buying assets for its outreach laboratory business.
Request a free sample copy or view report summary: Clinical Laboratory Services Market Report
Based on test type, the clinical chemistry segment led the market with the largest revenue share of 56.60% in 2024.
Based on service provider, the hospital-based laboratories segment accounted for the largest market share in 2024.
Based on application, the bioanalytical & lab chemistry services segment accounted for the largest revenue share in 2024.
North America dominated the clinical laboratory services market with the largest revenue share of 37.24% in 2024.
Grand View Research has segmented the global clinical laboratory service market on the basis of test type, application, service provider, and region:
Clinical Laboratory Services Test Type Outlook (Revenue, USD Million, 2018 - 2030)
Genetic Testing
Clinical Chemistry
Routine Chemistry Testing
Therapeutic Drug Monitoring Testing
Endocrinology Chemistry Testing
Specialized Chemistry Testing
Other Clinical Chemistry Testing
Medical Microbiology Testing
Infectious Disease Testing
Transplant Diagnostic Testing
Other Microbiology Testing
Hematology Testing
Immunology Testing
Cytology Testing
Drug of Abuse Testing
Other Esoteric Tests
Clinical Laboratory Services Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
Hospital-Based Laboratories
Stand-Alone Laboratories
Clinic-Based Laboratories
Clinical Laboratory Services Application Outlook (Revenue, USD Million, 2018 - 2030)
Bioanalytical & Lab Chemistry Services
Toxicology Testing Services
Cell & Gene Therapy Related Services
Preclinical & Clinical Trial Related Services
Drug Discovery & Development Related Services
Other Clinical Laboratory Services
Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Colombia
Peru
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Clinical Laboratory Services Market
Laboratory Corporation of America Holdings (LabCorp)
QIAGEN
Eurofins Scientific
Quest Diagnostics Incorporated
OPKO Health, Inc.
Siemens Healthineers AG
NeoGenomics Laboratories.
Fresenius Medical Care.
ARUP Laboratories.
Sonic Healthcare Limited
Charles River Laboratories.
SYNLAB International
Mayo Clinic Laboratories
Unilabs
"The quality of research they have done for us has been excellent..."